Is There a Link Between Diet and Mental Health?

Why It Matters

Demonstrating a clinically effective, diet‑based adjunct for bipolar disorder could broaden treatment options and reduce reliance on medications with significant side effects, but only robust trials can validate its safety and durability.

Key Takeaways

• Keto diet shows promise as adjunct for bipolar depression treatment.
• Early feasibility studies indicate changes in brain glutamate via MR spectroscopy.
• Mechanisms remain speculative: energy efficiency, mitochondrial function, inflammation, gut microbiome.
• Philanthropic funding has driven pilot trials, but large RCTs are still needed.
• Long‑term adherence challenges persist; diet should complement, not replace, standard meds.

Summary

The Lancet podcast explores whether a ketogenic diet can influence mental health, focusing on its emerging role in managing bipolar disorder. Host Niall Boyce and guest Daniel "Danny" Smith discuss the diet’s composition—high fat, low carbohydrate—and its historical use for epilepsy before turning to psychiatric applications.

Recent case reports and a small feasibility study of 20 bipolar patients suggest the diet may alter brain metabolites, notably glutamate, as measured by magnetic resonance spectroscopy. The upcoming "Energize BD" trial will expand this work, tracking changes in glutamate‑GABA balance, lactate, and ATP over 12 weeks to link metabolic shifts with symptom improvement.

Smith emphasizes that proposed mechanisms—enhanced neuronal energy efficiency, mitochondrial support, reduced neuroinflammation, and gut‑brain axis modulation—remain speculative. He notes philanthropic funding has jump‑started pilot work, but stresses that only well‑designed, adequately powered randomized controlled trials can separate hype from genuine therapeutic benefit. Similar investigations are underway for schizophrenia, Parkinson’s, multiple sclerosis, and even eating disorders.

If rigorous trials confirm efficacy, a ketogenic regimen could become a low‑side‑effect adjunct for bipolar depression, offering patients greater agency over treatment. However, long‑term adherence challenges and the need to integrate diet with established pharmacotherapies underscore the importance of cautious, evidence‑based implementation.

Original Description

In this episode of The Lancet Pulse, Niall Boyce and Matt Gilbert speak with Professor Daniel Smith about the emerging connection between diet and mental health, with a focus on the ketogenic diet and bipolar disorder. Together, they explore what bipolar disorder is, why its depressive phases can be so difficult to treat, and why researchers are beginning to investigate whether changes in metabolism and brain energy use could play a role in improving symptoms.

The conversation also looks at the bigger picture: how much evidence is there so far, what makes this area of research so promising, and where caution is still needed. From early feasibility studies to questions about long-term safety, affordability, and dietitian support, this episode offers a thoughtful look at a fast-evolving field — and asks whether nutritional approaches could become a meaningful add-on to mental health care in the future.

The Lancet Pulse is part of the Lancet Group podcast offering. 

Editorial team: Chloe Wilson, Ben Abbott, Matthew Gilbert, and Jonathan Pimm

Podcast editing and production: Matteo Simonetti

Visit https://www.thelancet.com/multimedia (https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm)  to learn more about our multimedia offering. 

Find the best science for better lives at https://www.thelancet.com

Follow us today at...

https://thelancet.bsky.social/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://linkedIn.com/company/the-lancet (https://linkedin.com/company/the-lancet)

https://youtube.com/thelancettv (https://www.youtube.com/thelancettv)